Suppr超能文献

DNA甲基化在癌症各阶段中的作用

The Roles of DNA Methylation in the Stages of Cancer.

作者信息

McMahon K Wyatt, Karunasena Enusha, Ahuja Nita

机构信息

From the Departments of *Surgery, †Oncology, ‡Cancer Immunology, and §Urology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD.

出版信息

Cancer J. 2017 Sep/Oct;23(5):257-261. doi: 10.1097/PPO.0000000000000279.

Abstract

Next year will mark 60 years since Dr. Leslie Foulds outlined his hypothesis that cancer is "a dynamic process advancing through stages that are qualitatively different," leading the way to our view of cancer progression as we know it today. Our understanding of the mechanisms of these stages has been continuously evolving this past half-century, and there has always been an active discussion of the roles of both genetic and epigenetic changes in directing this progression. In this review, we focus on the roles one particular epigenetic mark-DNA methylation-plays in these various "discontinuous" stages of cancer. Understanding these steps not only gives us a better picture of how this fascinating biological process operates, but also opens the doors to new prognostic biomarkers and therapies against these malignancies.

摘要

明年将迎来莱斯利·福尔兹博士提出其假说60周年。该假说认为癌症是“一个通过性质不同的阶段不断发展的动态过程”,为我们如今所知的癌症进展观点奠定了基础。在过去的半个世纪里,我们对这些阶段机制的理解一直在不断发展,并且对于基因和表观遗传变化在引导这一进展过程中的作用一直存在着积极的讨论。在这篇综述中,我们聚焦于一种特定的表观遗传标记——DNA甲基化——在癌症这些不同的“不连续”阶段中所起的作用。了解这些步骤不仅能让我们更好地了解这个迷人的生物学过程是如何运作的,还为针对这些恶性肿瘤的新的预后生物标志物和治疗方法打开了大门。

相似文献

1
The Roles of DNA Methylation in the Stages of Cancer.
Cancer J. 2017 Sep/Oct;23(5):257-261. doi: 10.1097/PPO.0000000000000279.
2
The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.
Oncotarget. 2016 Jun 14;7(24):37331-37346. doi: 10.18632/oncotarget.7949.
3
DNA Methylation-Targeted Drugs.
Cancer J. 2017 Sep/Oct;23(5):270-276. doi: 10.1097/PPO.0000000000000278.
4
Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
Epigenomics. 2015 Oct;7(7):1083-8. doi: 10.2217/epi.15.66. Epub 2015 Nov 6.
6
Epigenetic drugs take on cancer.
Science. 2010 Oct 29;330(6004):576-8. doi: 10.1126/science.330.6004.576.
7
DNA methylation: its role in cancer development and therapy.
Curr Probl Cancer. 2008 Sep-Oct;32(5):187-235. doi: 10.1016/j.currproblcancer.2008.08.002.
8
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
Int J Cancer. 2008 Jul 1;123(1):8-13. doi: 10.1002/ijc.23607.
9
Epigenetic biomarkers.
Curr Top Microbiol Immunol. 2012;355:189-216. doi: 10.1007/82_2011_165.
10
DNA methyltransferase inhibitors for cancer therapy.
Cancer J. 2007 Jan-Feb;13(1):17-22. doi: 10.1097/PPO.0b013e31803c7245.

引用本文的文献

1
The catalytic efficiency of METTL16 affects cellular processes by governing the intracellular S-adenosylmethionine setpoint.
Cell Rep. 2025 Jul 22;44(7):115966. doi: 10.1016/j.celrep.2025.115966. Epub 2025 Jul 10.
3
Longitudinal prediction of DNA methylation to forecast epigenetic outcomes.
EBioMedicine. 2025 May;115:105709. doi: 10.1016/j.ebiom.2025.105709. Epub 2025 Apr 22.
5
DNA Methylation in Colorectal Cancer as Potential Prognostic and Predictive Markers.
Biomolecules. 2025 Jan 10;15(1):104. doi: 10.3390/biom15010104.
6
A Landscape of Cancer Initiation and Cancer Stem Cells.
Cancers (Basel). 2025 Jan 9;17(2):203. doi: 10.3390/cancers17020203.
7
Accurate identification of primary site in tumors of unknown origin (TUO) using DNA methylation.
NPJ Precis Oncol. 2025 Jan 10;9(1):8. doi: 10.1038/s41698-025-00805-z.
8
MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing.
Bioinformatics. 2024 Sep 2;40(9). doi: 10.1093/bioinformatics/btae522.
9
Contribution of the seminal microbiome to paternal programming.
Biol Reprod. 2024 Aug 15;111(2):242-268. doi: 10.1093/biolre/ioae068.
10
Mutuality of epigenetic and nanoparticles: two sides of a coin.
Heliyon. 2023 Dec 13;10(1):e23679. doi: 10.1016/j.heliyon.2023.e23679. eCollection 2024 Jan 15.

本文引用的文献

1
DNA methylation markers for diagnosis and prognosis of common cancers.
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7414-7419. doi: 10.1073/pnas.1703577114. Epub 2017 Jun 26.
3
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.
4
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells.
PLoS One. 2017 Apr 26;12(4):e0176139. doi: 10.1371/journal.pone.0176139. eCollection 2017.
6
Targeting isocitrate dehydrogenase (IDH) in cancer.
Discov Med. 2016 May;21(117):373-80.
7
[Fecal Biomarker for Colorectal Cancer Diagnosis].
Rinsho Byori. 2015 Mar;63(3):361-8.
8
Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives.
World J Gastrointest Oncol. 2015 Oct 15;7(10):178-83. doi: 10.4251/wjgo.v7.i10.178.
10
Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.
Epigenetics. 2015;10(6):545-61. doi: 10.1080/15592294.2015.1048953.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验